Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

MMR, measles, and the South Wales Evening Post.

McCartney M.

BMJ. 2013 Apr 22;346:f2598. doi: 10.1136/bmj.f2598. No abstract available.

PMID:
23610382
2.

MMR vaccination: protecting our children.

Moreton J.

J Fam Health Care. 2002;12(2):31. No abstract available.

PMID:
12415749
3.

Vaccines for measles, mumps and rubella in children.

Demicheli V, Jefferson T, Rivetti A, Price D.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004407. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD004407.

PMID:
16235361
4.

Wales sets up drop-in vaccination clinics to tackle measles outbreak.

Iacobucci G.

BMJ. 2013 Apr 16;346:f2452. doi: 10.1136/bmj.f2452. No abstract available.

PMID:
23592583
5.

MMR: where are we now?

Elliman D, Bedford H.

Arch Dis Child. 2007 Dec;92(12):1055-7. Epub 2007 Jul 11. Review. No abstract available.

7.

MMR and the measles crisis.

Murphy JF.

Ir Med J. 2000 Mar-Apr;93(2):36. No abstract available. Erratum in: Ir Med J 2000 May;93(3):68.

PMID:
11037244
8.

Measles-mumps-rubella vaccine and autism: the rise (and fall?) of a hypothesis.

Kastner JL, Gellin BG.

Pediatr Ann. 2001 Jul;30(7):408-15. No abstract available.

PMID:
11469172
9.

MMR catch-up project launched to prevent further measles outbreaks.

[No authors listed]

Community Pract. 2013 Jun;86(6):4. No abstract available.

PMID:
23821873
10.

Measles outbreaks in a population with declining vaccine uptake.

Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ.

Science. 2003 Aug 8;301(5634):804. No abstract available.

11.

MMR vaccine: review of benefits and risks.

Miller E.

J Infect. 2002 Jan;44(1):1-6. Review. No abstract available.

PMID:
11972410
12.

The truth behind the MMR headlines.

Bedford H.

J Fam Health Care. 2013 May;23(4):6-8. No abstract available.

PMID:
23914607
13.

Largest group of children affected by measles outbreak in Wales is 10-18 year olds.

Wise J.

BMJ. 2013 Apr 19;346:f2545. doi: 10.1136/bmj.f2545. No abstract available.

PMID:
23604089
14.
15.

On the 2002 measles vaccination furore in the UK.

Spier RE.

Vaccine. 2002 Jul 26;20(23-24):2845-7. No abstract available.

PMID:
12126892
16.

MMR vaccine and autism: an update of the scientific evidence.

DeStefano F, Thompson WW.

Expert Rev Vaccines. 2004 Feb;3(1):19-22. Review.

PMID:
14761240
17.

Measles, mumps, rubella (MMR) vaccine.

Dubey AP, Banerjee S.

Indian J Pediatr. 2003 Jul;70(7):579-84.

PMID:
12940381
18.

The importance of giving voice to parents' concerns about the MMR vaccine.

Spear HJ.

Med Sci Monit. 2005 Oct;11(10):LE13-4. Epub 2005 Sep 26. No abstract available.

PMID:
16192905
19.

Measles vaccines and the potential for worldwide eradication of measles.

Meissner HC, Strebel PM, Orenstein WA.

Pediatrics. 2004 Oct;114(4):1065-9.

PMID:
15466106
20.

Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.

Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G.

Pediatr Infect Dis J. 2005 Dec;24(12):1083-8.

PMID:
16371870

Supplemental Content

Support Center